{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:37:51Z","timestamp":1792723071391,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaci.2026.07.028","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:02:18Z","timestamp":1790780538000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostaglandin E2 protects against MRGPRX2\/Mrgprb2-mediated and aspirin-aggravated anaphylaxis via modulation of mast cell activation"],"prefix":"10.1016","author":[{"given":"Payam","family":"Morakabati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Globig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Babina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3449-1245","authenticated-orcid":false,"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.07.028_bib1","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.jaip.2023.03.015","article-title":"Research advances in mast cell biology and their translation into novel therapies for anaphylaxis","volume":"11","author":"Dispenza","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.028_bib2","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.028_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jaci.2018.10.034","article-title":"Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2\/MRGPRX2-mediated mast cell activation","volume":"143","author":"Takamori","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00281-025-01056-7","article-title":"IgE and non-IgE\u2013mediated pathways in anaphylaxis","volume":"47","author":"Worm","year":"2025","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaci.2026.07.028_bib5","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1016\/j.jaip.2021.05.042","article-title":"Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis","volume":"9","author":"Deepak","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.028_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1155777","article-title":"GRK2 differentially regulates Fc\u03b5RI and MRGPRB2-mediated responses in mast cells","volume":"14","author":"Thapaliya","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/cells8040341","article-title":"IL-33 and MRGPRX2-triggered activation of human skin mast cells\u2014elimination of receptor expression on chronic exposure, but reinforced degranulation on acute priming","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2026.07.028_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/cells11060953","article-title":"MRGPRX2-mediated degranulation of human skin mast cells requires the operation of G\u03b1i, G\u03b1q, Ca++ channels, ERK1\/2 and PI3K\u2014interconnection between early and late signaling","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2026.07.028_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/itx.0000000000000032","article-title":"The pseudo-allergic\/neurogenic route of mast cell activation via MRGPRX2: discovery, functional programs, regulation, relevance to disease, and relation with allergic stimulation","volume":"5","author":"Babina","year":"2020","journal-title":"Itch"},{"key":"10.1016\/j.jaci.2026.07.028_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted MRGPRX2: new insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676354","article-title":"MRGPRX2 and adverse drug reactions","volume":"12","author":"McNeil","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib12","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3390\/cells10112906","article-title":"Therapeutic potential of MRGPRX2 inhibitors on mast cells","volume":"10","author":"Ogasawara","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2026.07.028_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.iac.2021.09.011","article-title":"Pathophysiology of immunologic and nonimmunologic systemic reactions including anaphylaxis","volume":"42","author":"Fowler","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2026.07.028_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/intimm\/dxz021","article-title":"Molecular mechanisms underlying prostaglandin E2\u2013exacerbated inflammation and immune diseases","volume":"31","author":"Tsuge","year":"2019","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1100\/tsw.2007.182","article-title":"Prostaglandin receptor signaling in disease","volume":"7","author":"Matsuoka","year":"2007","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jaci.2026.07.028_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/BJ20090420","article-title":"Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation","volume":"422","author":"Zahner","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.jaci.2026.07.028_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.anai.2019.09.003","article-title":"Suppression of aspirin-mediated eosinophil activation by prostaglandin E2: relevance to aspirin and nonsteroidal anti-inflammatory drug hypersensitivity","volume":"123","author":"Pal","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175397","article-title":"Acetylsalicylic acid aggravates anaphylaxis in a PGE 2\u2013dependent manner","volume":"135","author":"Globig","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.028_bib19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jaci.2020.03.046","article-title":"PGE2 deficiency predisposes to anaphylaxis by causing mast cell hyperresponsiveness","volume":"146","author":"Rastogi","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib20","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/ijms22073580","article-title":"Cytokines stimulated by IL-33 in human skin mast cells: involvement of NF-\u03baB and p38 at distinct levels and potent co-operation with Fc\u03b5RI and MRGPRX2","volume":"22","author":"Franke","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.07.028_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/all.13301","article-title":"Allergic Fc\u03b5RI- and pseudo-allergic MRGPRX 2\u2013triggered mast cell activation routes are independent and inversely regulated by SCF","volume":"73","author":"Babina","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.028_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1189\/jlb.0403157","article-title":"Comparative cytokine profile of human skin mast cells from two compartments\u2014strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming","volume":"75","author":"Babina","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2026.07.028_bib23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/exd.13358","article-title":"An efficient method for gene knock-down by RNA interference in human skin mast cells","volume":"26","author":"Hazzan","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2026.07.028_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jid.2020.09.017","article-title":"MRGPRX2 is the codeine receptor of human skin mast cells: desensitization through \u03b2-arrestin and lack of correlation with the Fc\u03b5RI pathway","volume":"141","author":"Babina","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.07.028_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/cells10010102","article-title":"Thymic stromal lymphopoietin promotes MRGPRX2-triggered degranulation of skin mast cells in a STAT5-dependent manner with further support from JNK","volume":"10","author":"Babina","year":"2021","journal-title":"Cells"},{"issue":"7542","key":"10.1016\/j.jaci.2026.07.028_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell\u2013specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.07.028_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.intimp.2019.02.001","article-title":"Mast cell\u2013mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent","volume":"70","author":"Liu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2026.07.028_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.547","article-title":"MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions","volume":"7","author":"Grimes","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jaci.2026.07.028_bib29","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/itx.0000000000000005","article-title":"MRGPRX2, atopic dermatitis, and red man syndrome","volume":"2","author":"Azimi","year":"2017","journal-title":"Itch"},{"key":"10.1016\/j.jaci.2026.07.028_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41467-023-36463-7","article-title":"Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.07.028_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.18176\/jiaci.1070","article-title":"Prostaglandin E2: a potential link between NSAIDs and the menstrual cycle, cofactors of food-dependent anaphylaxis","volume":"35","author":"Tubita","year":"2025","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2332\/allergolint.R-08-163","article-title":"Targeting human mast cells expressing G-protein\u2013coupled receptors in allergic diseases","volume":"57","author":"Okayama","year":"2008","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.07.028_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-016-0598-5","article-title":"Mast cells and anaphylaxis","volume":"16","author":"Lieberman","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2026.07.028_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1067\/mai.2002.125977","article-title":"The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis","volume":"110","author":"Makabe-Kobayashi","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adc9417","article-title":"A mast cell\u2013thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis","volume":"8","author":"Bao","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41577-023-00875-9","article-title":"Mast cells chill in anaphylaxis","volume":"23","author":"Bordon","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib37","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/S0021-9258(19)50448-3","article-title":"Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype","volume":"267","author":"Sugimoto","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2026.07.028_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0091-6749(81)90134-2","article-title":"Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responses","volume":"68","author":"Kaliner","year":"1981","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00005344-198307000-00004","article-title":"Cardiovascular effects of histamine infusion in man","volume":"5","author":"Vigorito","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jaci.2026.07.028_bib40","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/all.12227","article-title":"Anaphylactic responses to histamine in mice utilize both histamine receptors 1 and 2","volume":"68","author":"Wechsler","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.028_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4049\/jimmunol.173.1.559","article-title":"Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor\u2013mediated increase in intracellular cyclic AMP","volume":"173","author":"Aronoff","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjp.0706664","article-title":"Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation","volume":"147","author":"Kay","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2026.07.028_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1165\/rcmb.2004-0126OC","article-title":"Prostaglandin E2 inhibits fibroblast migration by E-prostanoid 2 receptor\u2013mediated increase in PTEN activity","volume":"32","author":"White","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2026.07.028_bib44","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jcb.24732","article-title":"Different role of cAMP pathway on the human mast cells HMC-1560 and HMC-1560,816 activation","volume":"115","author":"Barreiro-Costa","year":"2014","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jaci.2026.07.028_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10555-011-9303-2","article-title":"Prostaglandin E2 EP receptors as therapeutic targets in breast cancer","volume":"30","author":"Reader","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jaci.2026.07.028_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/mi.2009.136","article-title":"Advances in mast cell biology: new understanding of heterogeneity and function","volume":"3","author":"Moon","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib47","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/cells10071615","article-title":"Two sides of the coin: mast cells as a key regulator of allergy and acute\/chronic inflammation","volume":"10","author":"Zhang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2026.07.028_bib48","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies","volume":"147","author":"K\u00fchn","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib49","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1073\/pnas.0701700104","article-title":"Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3","volume":"104","author":"Weller","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.07.028_bib50","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/S0021-9258(18)53832-1","article-title":"Two isoforms of the EP3 receptor with different carboxyl-terminal domains. Identical ligand binding properties and different coupling properties with Gi proteins","volume":"268","author":"Sugimoto","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2026.07.028_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-1033.1993.tb18248.x","article-title":"Third isoform of the prostaglandin-E\u2013receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase","volume":"217","author":"Irie","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jaci.2026.07.028_bib52","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cell.2018.12.036","article-title":"The cis-regulatory atlas of the mouse immune system","volume":"176","author":"Yoshida","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.07.028_bib53","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","article-title":"Activation of mast-cell\u2013expressed mas-related G-protein\u2013coupled receptors drives non-histaminergic itch","volume":"50","author":"Meixiong","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.07.028_bib54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.anai.2015.08.014","article-title":"Increased basophil activation in adult patients with anaphylaxis","volume":"115","author":"Kim","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib55","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/all.14615","article-title":"Prostaglandin E2 decreases basophil activation in patients with food-induced anaphylaxis","volume":"76","author":"Mu\u00f1oz-Cano","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.028_bib56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.104.074823","article-title":"Effects of prostaglandin D2 and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils","volume":"312","author":"Monneret","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2026.07.028_bib57","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaci.2012.05.008","article-title":"Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking","volume":"131","author":"Konya","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.028_bib58","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1111\/bph.13229","article-title":"Activation of EP 4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function","volume":"172","author":"Konya","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2026.07.028_bib59","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell\u2013mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"7493","key":"10.1016\/j.jaci.2026.07.028_bib60","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature13182","article-title":"A promoter-level mammalian expression atlas","volume":"507","author":"Forrest","year":"2014","journal-title":"Nature"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926006779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926006779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:50:06Z","timestamp":1792720206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926006779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"alternative-id":["S0091674926006779"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.028","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostaglandin E2 protects against MRGPRX2\/Mrgprb2-mediated and aspirin-aggravated anaphylaxis via modulation of mast cell activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}